Sigilon Therapeutics

Sigilon Therapeutics

Sigilon Therapeutics is a biotechnology company developing immunotherapies for the treatment of chronic diseases.

Sigilon Therapeutics is a biotechnology company developing immunotherapies for the treatment of chronic diseases that is headquartered in Cambridge, Massachusetts and was founded in 2015 by Daniel Anderson, Robert Langer, Jose Oberholzher, Arturo Vegas, and Omid Veiseh.

The company looks to engineer human cells that are capable of restoring to a normal physiology after a range of diseases, and doing so without generating fibrosis, or immune rejection. They operate in fields of biotechnology, hemophilia, diabetes, lysosomal storage disorders, bio-compatible materials, and chronic disease solutions.

Sigilon Therapeutics has the goal of creating what they refer to as Shielded Living Therapeutics, which are engineered cells that provide a functional cure for chronic diseases. They have completed trials of their therapeutics in animals, and predict that should they succeed in human cases, these solutions will help generate the natural biomolecules a patient requires to maintain therapeutic protein replacement over long-term periods.

Timeline

People

Name
Role
LinkedIn

Arturo Vegas

Co-Founder

Daniel Anderson

Co-Founder

Jose Oberholzher

Co-Founder

Omid Veiseh

Co-Founder

Robert Langer

Co-Founder

Further reading

Title
Author
Link
Type
Date

Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes

Eli Lilly and Company

Web

Sigilon Therapeutics and MIT Announce Research Collaboration to Advance Programmable Living Therapeutics for Serious Chronic Diseases

Business Wire

Web

Sigilon Therapeutics Expands Intellectual Property Portfolio with New Patent Issued

Sigilon Therapeutics

Web

With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells

David Holley

Web

Documentaries, videos and podcasts

Title
Date
Link

Sigilon Therapeutics

October 18, 2018

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.